TrialCast Verified

We find the money your CRO owes you and help you recover it. It costs you nothing to start.

CRO invoice recovery audit. Our fee comes only from what we recover.

Talk to us about one of your trials

CRO invoices are hard to check, so overbilling goes unnoticed.

  • Billing drifts past the contract. Extra units, out-of-scope lines and late change orders.
  • The CRO reports its own work. The vendor that bills is also the source of the numbers. Trust, but verify.
  • Too detailed to check by hand. Few finance teams can tie every line back to the contract.
Units billed vs. units contracted Illustrative

The result:

Money paid that was never owed
An accrual that is hard to defend at year end
57% of protocols have at least one substantial amendment, at a median direct cost of $535k in Phase III. Each amendment usually means a CRO change order. Tufts CSDD, 2016

How it works

The result: every charge is credit due, needs backup, or matches the contract

A credit request out.

  • Credit due. Billed beyond contract. Credit request drafted for you.
  • Needs backup. A document or the CRO's records will settle it.
  • Matches the contract. No action.

For any sponsor with a CRO-run trial under way or in close-out.

  • Under way or in close-out Credits come off invoices that are still open, including the final ones.
  • 12+ months of CRO invoices Enough CRO billing to test against the contract.
  • The documents Contract and change orders, invoices, site budgets, EDC export.

Talk to us about one of your trials

Start small. The decisions stay yours.

  1. One-page preview

    Sign an NDA and send your CRO contract, change orders and invoices. A one-page preview tells you if a full audit is worth it. No cost, and no commitment beyond sending the documents.

  2. Full audit

    If you want to proceed to the full audit and recovery, add the site budgets and the EDC export. Findings once the document set is complete.

  3. Help with the request

    We draft the credit request and help you recover the money.

No cost to start. Our fee comes only from what we recover.

No upfront fee The one-page preview and the audit cost you nothing to start.
A share of what we recover Paid only when money actually comes back to you.
Nothing recovered, nothing owed If we recover nothing, you pay nothing.

Recovered means credits applied against your invoices, refunds received, or invoice reductions taken, not credits promised.

Your data stays yours.

  • People sign your NDA Everyone who sees your documents signs a mutual NDA first.
  • AI never trains on it We use only AI services contractually barred from training on your data.
  • Only what we need EDC exports carry subject IDs, statuses and visit dates. No patient names.
  • Kept separate Each client's data is held on its own and never used for anyone else.
  • Returned or deleted At the end of the engagement, your way.
  • A person signs off A named reviewer stands behind every finding.

Questions we're asked

Not yet; we're working toward it. Until then: everyone who sees your documents signs your NDA first, your data is held separately from any other client's, a named person reviews every finding, and the AI we use is barred by contract from training on your data.

Yes. AI and machine learning do the line-by-line checks, and a person reviews the findings. We use AI services under commercial terms that bar training on customer data, with limited retention. Nothing is shared with any other client.

No names. We need the EDC visit export: subject IDs, statuses and visit dates, because each visit has a contract price. That is pseudonymized research data, and we treat it that way. We'll sign data-protection terms with you before any data is shared.

Your NDA covers it, and enrollment and safety data stay with the named reviewer. Anyone on our side follows your insider trading policy. You decide whether, when and how any finding is disclosed.

In your own system (Box or similar); you give us access. If you don't have one, we provide a dedicated folder. Files are returned or deleted at the end, your way.

Holly Lujan, our CFO, reviews every audit: fifteen years in clinical-stage finance and Director of FP&A at multiple companies. The software does the matching; she signs off.

No. It's a recovery audit and reconciliation: we find billing that doesn't match your contract and document it. It is not an audit, review or attest engagement, and we don't give legal advice.

Nothing to start. Our fee is a share of what we recover, paid only when money actually comes back to you; if we recover nothing, you pay nothing. We agree the rate with you in the engagement letter. "Recovered" means credits applied against your invoices, refunds received, or invoice reductions taken.

To start, very little. After we sign an NDA, a one-page preview of your CRO contract, change orders and invoices tells you whether a full audit is worth it. No cost, and no commitment beyond sending the documents. If it is, add the site budgets and the EDC export; findings with evidence follow once the document set is complete. Getting the CRO's backup is usually the slow part, and we give you a checklist and a ready-made request letter for it.

You do, and only if you choose to. We draft the credit request with the contract clause and the invoice line behind each item; nothing goes to your CRO without your say-so.

Every item is evidenced against the contract they signed, which is the strongest footing for a credit request.

We won't quote a typical recovery until our audits have realized credits. Every finding comes with the contract clause and the invoice line behind it. Billing tends to drift when the work changes: a 2016 Tufts CSDD study found 57% of protocols have at least one substantial amendment, at a median direct cost of $535k in Phase III, and amendments are the primary trigger for CRO change orders.

Any sponsor with a CRO-run trial under way or in close-out, 12 months or more of CRO invoices, and the documents.

Yes, professional liability insurance.

Clinical finance, built into software.

Holly Lujan

COO and CFO

Director of FP&A at multiple companies. Fifteen years in clinical-stage finance, through a public offering, a reverse merger and a pharma acquisition valued at up to $1.5bn. Her financial models have been the basis for over $450mm in capital raises. Holly reviews every audit.

Jesse Lujan

CEO and CTO

Former Chief Product Officer at two enterprise software companies, and a decade of biotech experience.

Greg Curhan

Executive Chairman

CFO of multiple public and private life sciences companies. 40+ years of financial and capital markets experience.

Next step: a short call to look at one of your trials.

Please don't send documents or patient data through this form.

This form collects your name, work email, company and note so we can reply to you. We use them for nothing else. See the CaladanAI privacy policy.

TrialCast Verified, by CaladanAI.